Letters
Outpatient parenteral antimicrobial therapy
OPAT outcomes in endocarditis
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2484 (Published 24 April 2013) Cite this as: BMJ 2013;346:f2484- Christopher J A Duncan, research fellow12,
- David A Barr, specialist registrar2,
- R Andrew Seaton, consultant in infectious diseases and general medicine2
- 1Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK
- 2Gartnavel General Hospital, Glasgow, Glasgow G12 0YN, UK
- chrisduncan{at}doctors.net.uk
As Chapman states,1 outpatient parenteral antibiotic therapy (OPAT) is increasingly seen as a viable management option for high risk patients with infective endocarditis. But in most studies treatment success is judged on clinical grounds (such as cure of infection). Because the benefits of this treatment derive from avoiding hospital admission while providing high standards of care to “low risk” patients, judgment on the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.